Marie-Louise Lyster, Author at Novo Nordisk Pharmatech

Where to meet us in 2025

Join us at the most important conferences in 2025. Our teams of experts will be there to answer all your questions, especially about our Recombinant Insulin and TrypsiNNex®. We will exhibit at: Biologics Manufacturing Asia at Marina Bay Sands Expo & Convention Centre in Singapore, March 12-13, 2025 World Vaccine Congress US at Walter E […]

Novo Nordisk Pharmatech launches TrypsiNNex®

Today marks an important milestone at Novo Nordisk Pharmatech as we announce the launch of TrypsiNNex® – a new recombinant enzyme in the company portfolio. This product represents a key part of our growth strategy in the specialty enzymes sector for pharmaceutical manufacturing. TrypsiNNex® is a sustainable, animal-free trypsin product that will enable the production […]

We will attend BPI US 2024

We are thrilled to announce our attendance at the upcoming BioProcess International Congress, which will take place September 24-26 at Hynes Convention Center in Boston! We will showcase one of our key specialities, Recombinant Insulin, at booth 814. Approved by the FDA and EMA, our animal-free Insulin is a vital ingredient in over 100 therapeutic […]

Novo Nordisk Pharmatech is investing 1.5 billion Danish kroner in a new factory in Køge

In order to meet significantly higher demand from Novo Nordisk A/S for raw materials for the production of medicines to fight chronic diseases, Novo Nordisk Pharmatech A/S is building a new factory at Ådalen 16 in Køge. In March 2023, Novo Nordisk Pharmatech announced the purchase of a 47,000 m² site in Køge, with the […]